BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, March 25, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Aug. 30, 2012
View Archived Issues
New orally bioavailable renin inhibitor developed by Daiichi Sankyo
Read More
Candidate analgesic releases pregabalin and nitric oxide
Read More
Novel candidate drug for heart failure completes phase I trial
Read More
Nucynta ER approved for new indication in U.S.
Read More
Pfizer presents first-in-human data on new PDE2A inhibitor for schizophrenia
Read More
Zytiga sNDA receives priority review status
Read More
Proacta obtains FDA clearance for clinical PR-610 study
Read More
New drug candidate shows potential as treatment for malaria
Read More
Phase III lomitapide study reaches week 78
Read More
Lilly discontinues phase III development of schizophrenia drug
Read More
Confirmatory U.S. phase III trial begins for Scenesse
Read More
Treatment begins in CUPID study
Read More
Novel potential COPD therapies developed at GlaxoSmithKline
Read More
Idenix Pharmaceuticals designs new candidate hepatitis C drugs
Read More
Novartis discloses novel CDK9 inhibitors
Read More
Novel BCR-ABL inhibitors synthesized in China
Read More
Jinan Saiwen Pharmaceutical Technology reports new MEK inhibitors
Read More
Protalex reports encouraging results from PRTX-100 trial
Read More
Pfizer announces new launch of axitinib tablets
Read More
New data presented on Xiaflex in Peyronie's disease
Read More
Eisai seeks Japanese approval for antiepileptic agent
Read More
Bayer HealthCare receives European label extension
Read More
FDA approves Teva drug for chemotherapy-induced neutropenia
Read More
Kyowa Hakko Kirin suspends enrollment in phase III NSCLC study
Read More
Noven files NDA for therapy for menopausal vasomotor symptoms
Read More
